Autopsy report · NCT00946166

Impact of Statins on Cytokine Expression in Pneumonia

“Investigator left institution.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

The University of Texas Health Science Center at San Antonio

Sponsor type

University, hospital or other

Conditions

Community Acquired Pneumonia; Cardiovascular Risk Factors

Interventions

simvastatin; Placebo

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Intralesional Tetracycline Injection in the Treatment of Chalazia
  “Investigator left the institution” (95% match in meaning)
• Incisional Hernia Outcomes Study Using Parietex Composite Mesh
  “Principal Investigator left institution.” (93% match in meaning)
• Opioid Induced Loss of Local Anesthetic Potency in Patients Undergoing Total Knee Arthroplasty
  “Responsible Investigator left institution” (91% match in meaning)
• Use of Cast Iron Pots to Improve Maternal Anemia
  “Original investigator has left the institution.” (91% match in meaning)
• Study of Antibiotics in Cerebrospinal Fluid Following Intravenous Injection
  “Primary investigator left institution” (91% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.